Correlation Between AlzChem Group and MeVis Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AlzChem Group and MeVis Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AlzChem Group and MeVis Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AlzChem Group AG and MeVis Medical Solutions, you can compare the effects of market volatilities on AlzChem Group and MeVis Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AlzChem Group with a short position of MeVis Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of AlzChem Group and MeVis Medical.

Diversification Opportunities for AlzChem Group and MeVis Medical

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AlzChem and MeVis is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding AlzChem Group AG and MeVis Medical Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MeVis Medical Solutions and AlzChem Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AlzChem Group AG are associated (or correlated) with MeVis Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MeVis Medical Solutions has no effect on the direction of AlzChem Group i.e., AlzChem Group and MeVis Medical go up and down completely randomly.

Pair Corralation between AlzChem Group and MeVis Medical

Assuming the 90 days trading horizon AlzChem Group AG is expected to generate 2.75 times more return on investment than MeVis Medical. However, AlzChem Group is 2.75 times more volatile than MeVis Medical Solutions. It trades about 0.1 of its potential returns per unit of risk. MeVis Medical Solutions is currently generating about -0.02 per unit of risk. If you would invest  4,460  in AlzChem Group AG on October 13, 2024 and sell it today you would earn a total of  1,960  from holding AlzChem Group AG or generate 43.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.32%
ValuesDaily Returns

AlzChem Group AG  vs.  MeVis Medical Solutions

 Performance 
       Timeline  
AlzChem Group AG 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AlzChem Group AG are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, AlzChem Group may actually be approaching a critical reversion point that can send shares even higher in February 2025.
MeVis Medical Solutions 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MeVis Medical Solutions are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, MeVis Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

AlzChem Group and MeVis Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AlzChem Group and MeVis Medical

The main advantage of trading using opposite AlzChem Group and MeVis Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AlzChem Group position performs unexpectedly, MeVis Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MeVis Medical will offset losses from the drop in MeVis Medical's long position.
The idea behind AlzChem Group AG and MeVis Medical Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements